MedPath

COMPARISON OF TWO DRUGS IN THE TREATMENT OF ORAL LICHEN PLANUS

Phase 3
Conditions
Health Condition 1: L438- Other lichen planus
Registration Number
CTRI/2023/03/050453
Lead Sponsor
OT APPLICABLE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Healthy adults aged between 18 to 60 years.

2.Symptomatic patients having only Oral involvement of Lichen Planus which is biopsy proven and has not responded to any topical therapy for 3 months.(ODSS score >30)

Exclusion Criteria

1.Patients having extraoral involvement of Lichen Planus and erosive type of Lichen Planus

2.Patients with uncontrolled or severe hypertension, diabetes mellitus

3.Patients with active or recurrent infections, severe respiratory, renal, hepatic or heart disease

4.Patients with underlying endocrine or hematopoietic disorders

5.Patients who have a habit of tobacco chewing, beetle nut chewing and smoking.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Efficacy of Oral Cyclosporine vs Oral Steroid in the treatment of Oral Lichen Planus.Timepoint: At baseline,a monthly follow up of the patient for three months ,followed by 2 monthly visits for the next 6 months.
Secondary Outcome Measures
NameTimeMethod
Safety of Oral Cyclosporine vs Oral Steroid in the treatment of Oral Lichen PlanusTimepoint: At the end of follow up,that is at 9 months.
© Copyright 2025. All Rights Reserved by MedPath